Volitionrx Limited (NYSE: VNRX) reported Q3 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13).

Cash and cash equivalents as of September 30, 2016 totaled $12.5 million, compared with $14.5 million as of June 30, 2016 and $5.9 million as of December 31, 2015. As per previous press announcements, Volition raised an additional $12.4 million gross ($11.7 million net) proceeds from a public offering which closed in the fourth quarter.

For earnings history and earnings-related data on Volitionrx Limited (VNRX) click here.